Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1786 to 1800 of 2185 results for guidelines

  1. Glaucoma: diagnosis and management (CG85)

    This guidance has been updated and replaced by NICE guideline NG81.

    Withdrawn guideline

  2. Depression in children and young people: identification and management (CG28)

    This guidance has been updated and replaced by NICE guideline NG134.

    Withdrawn guideline

  3. Parkinson's disease in over 20s: diagnosis and management (CG35)

    This guidance has been updated and replaced by NICE guideline NG71.

    Withdrawn guideline

  4. Inducing labour (CG70)

    This guidance has been updated and replaced by NICE guideline NG207.

    Withdrawn guideline

  5. Attention deficit hyperactivity disorder: diagnosis and management (CG72)

    This guidance has been updated and replaced by NICE guideline NG87.

    Withdrawn guideline

  6. Surgical site infections: prevention and treatment (CG74)

    This guidance has been updated and replaced by NICE guideline NG125.

    Withdrawn guideline

  7. Acute kidney injury: prevention, detection and management (CG169)

    This guidance has been updated and replaced by NICE guideline NG148.

    Withdrawn guideline

  8. Hypertension (CG18)

    This guidance has been updated and replaced by NICE guideline CG34.

    Withdrawn guideline

  9. Chronic kidney disease in adults: assessment and management (CG182)

    This guidance has been updated and replaced by NICE guideline NG203.

    Withdrawn guideline

  10. Febuxostat for the management of hyperuricaemia in people with gout (TA164)

    This guidance has been updated and replaced by NICE guideline NG219.

    Withdrawn guidance

  11. Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure (TA48)

    This guidance has been updated and replaced by NICE guideline NG107 

    Withdrawn guidance

  12. The clinical effectiveness and cost effectiveness of anakinra for rheumatoid arthritis (TA72)

    This appraisal has been updated and replaced by NICE guideline CG79. 

    Withdrawn guidance

  13. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents (TA98)

    This guidance has been updated and replaced by NICE guideline NG87.

    Withdrawn guidance

  14. Chronic kidney disease: managing anaemia (NG8)

    This guidance has been updated and replaced by NICE guideline NG203.

    Withdrawn guideline

  15. BMI: preventing ill health and premature death in black, Asian and other minority ethnic groups (PH46)

    This guidance has been updated and replaced by NICE guideline CG189.

    Withdrawn guideline